XSpray Pharma (Sweden) Price on May 30, 2024
XSPRAY Stock | SEK 42.00 0.45 1.06% |
If you're considering investing in XSpray Stock, it is important to understand the factors that can impact its price. As of today, the current price of XSpray Pharma stands at 42.00, as last reported on the 27th of December, with the highest price reaching 42.45 and the lowest price hitting 41.40 during the day. XSpray Pharma AB shows Sharpe Ratio of -0.0625, which attests that the company had a -0.0625% return per unit of risk over the last 3 months. XSpray Pharma AB exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out XSpray Pharma's Standard Deviation of 3.39, market risk adjusted performance of 0.2807, and Mean Deviation of 2.21 to validate the risk estimate we provide.
XSpray Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
XSpray |
Sharpe Ratio = -0.0625
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | XSPRAY |
Estimated Market Risk
3.37 actual daily | 30 70% of assets are more volatile |
Expected Return
-0.21 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average XSpray Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of XSpray Pharma by adding XSpray Pharma to a well-diversified portfolio.
XSpray Pharma Valuation on May 30, 2024
It is possible to determine the worth of XSpray Pharma on a given historical date. On May 30, 2024 XSpray was worth 71.0 at the beginning of the trading date compared to the closed value of 68.1. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of XSpray Pharma stock. Still, in general, we apply an absolute valuation method to find XSpray Pharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of XSpray Pharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against XSpray Pharma's related companies.
Open | High | Low | Close | Volume | |
75.20 | 75.20 | 71.10 | 71.10 | 44,826 | |
05/30/2024 | 71.00 | 71.00 | 64.40 | 68.10 | 64,778 |
68.00 | 74.90 | 66.10 | 74.20 | 45,525 |
Backtest XSpray Pharma | | | XSpray Pharma History | | | XSpray Pharma Valuation | Previous | Next |
XSpray Pharma Trading Date Momentum on May 30, 2024
On May 31 2024 XSpray Pharma AB was traded for 74.20 at the closing time. The highest price during the trading period was 74.90 and the lowest recorded bid was listed for 66.10 . The volume for the day was 45.5 K. This history from May 31, 2024 contributed to the next trading day price jump. The trading price change to the next closing price was 8.96% . The trading price change to the current price is 5.43% . |
XSpray Pharma AB Fundamentals Correlations and Trends
By evaluating XSpray Pharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among XSpray Pharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. XSpray financial account trend analysis is a perfect complement when working with valuation or volatility modules.About XSpray Pharma Stock history
XSpray Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for XSpray is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in XSpray Pharma AB will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing XSpray Pharma stock prices may prove useful in developing a viable investing in XSpray Pharma
Xspray Pharma AB engages in developing protein kinase inhibitors for targeted cancer treatments in Sweden. Xspray Pharma AB was founded in 2003 and is based in Solna, Sweden. Xspray Pharma is traded on Stockholm Stock Exchange in Sweden.
XSpray Pharma Stock Technical Analysis
XSpray Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
XSpray Pharma Period Price Range
Low | December 27, 2024
| High |
0.00 | 0.00 |
XSpray Pharma AB cannot be verified against its exchange. Please verify the symbol is currently traded on Stockholm Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
XSpray Pharma December 27, 2024 Market Strength
Market strength indicators help investors to evaluate how XSpray Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading XSpray Pharma shares will generate the highest return on investment. By undertsting and applying XSpray Pharma stock market strength indicators, traders can identify XSpray Pharma AB entry and exit signals to maximize returns
XSpray Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for XSpray Pharma's price direction in advance. Along with the technical and fundamental analysis of XSpray Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of XSpray to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.03) | |||
Jensen Alpha | (0.15) | |||
Total Risk Alpha | (0.36) | |||
Treynor Ratio | 0.2707 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for XSpray Stock analysis
When running XSpray Pharma's price analysis, check to measure XSpray Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XSpray Pharma is operating at the current time. Most of XSpray Pharma's value examination focuses on studying past and present price action to predict the probability of XSpray Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XSpray Pharma's price. Additionally, you may evaluate how the addition of XSpray Pharma to your portfolios can decrease your overall portfolio volatility.
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |